Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
Clinical trial NCT07241819 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07241819
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-30
- Primary completion
- 2027-11-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.